Meyka AI API is live for developers.Start building.
Advertisement
Ernexa Therapeutics Inc. Warrants

Ernexa Therapeutics Inc. Warrants (ERNAW) Stock Overview

Explore Ernexa Therapeutics Inc. Warrants’s financial performance, market position, analyst ratings, and future outlook.

ERNAW●NASDAQ
Financial ServicesAsset Management
$0.06
$0.004(5.63%)
U.S. Market opens in 16h 57m
Advertisement

Ernexa Therapeutics Inc. Warrants (ERNAW)

Meyka AI Score

Z

Key Financials

Market Cap486.9K
P/E Ratio-0.00
EPS (TTM)$-6.95
ROE-2.64%
Fundamental Analysis

AI Price Forecasts

1 Month$0.05
3 Months$0.05
1 Year Target$0.00

ERNAW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ernexa Therapeutics Inc. Warrants (ERNAW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 486.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.48%
5-Day Change
-11.29%
1-Month Change
-55.61%
3-Month Change
74.93%
6-Month Change
-37.90%
Year-to-Date (YTD) Change
-37.90%
1-Year Change
-37.90%
3-Year Change
-37.90%
5-Year Change
-37.90%
All-Time (Max) Change
-37.90%

Contact Information

https://www.ernexatx.com
212 582 1199
1035 Cambridge Street, Cambridge, MA, 02141

Company Facts

60 Employees
IPO DateJul 12, 2024
CountryUS
Actively Trading

Frequently Asked Questions